Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel

Oncogene

Volumn 18, Issue 49, 1999, Pages 6925-6937

  Gilmore, Thomas D ^a  

^a Boston University   (United States)

Author keywords

Malignant transformation; NF B; Rel; Retroviral oncogene; Transcription factor; v Rel

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ONCOPROTEIN; ONCOPROTEIN V REL; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; CANCER GENETICS; CARCINOGENICITY; CELL CYCLE; CELL TRANSFORMATION; CELL TYPE; GENE MUTATION; HUMAN; HUMAN CELL; LEUKEMIA; LYMPHOMA; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; TRANSACTIVATION;

ANIMALIA; AVES; MAMMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0033596128     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203222     Document Type: Review

References (176)

1. Abbadie C, Kabrun N, Bouali F, Smardova J, Stéhelin D, Vandenbunder B and Enrietto PJ. (1993). Cell, 75, 899-912.
2. Ballard DW, Walker WH, Doerre S, Sista P, Molitor JA, Dixon EP, Peffer NJ, Hannink M and Greene WC. (1990). Cell, 63, 803-814.
3. Barbacid M, Hunter E and Aaronson SA. (1979). J. Virol., 30, 508-514.
4. Barkett M and Gilmore TD. (1999). Oncogene, 18, 6910-6924.
5. Barkett M, Dooher JE, Lemonnier L, Simmons L, Wang Y and Gilmore TD. (1999). Oncogene, submitted.
6. Barth CF and Humphries EH. (1998a). J. Exp. Med., 167, 89-108.
7. Barth CF and Humphries EH. (1988b). Mol. Cell. Biol., 8, 5358-5368.
8. Barth CF, Ewert DL, Olson WC and Humphries EH. (1990). J. Virol., 64, 6054-6062.
9. Bash J, Zong W-X and Gélinas C. (1997). Mol. Cell. Biol., 17, 6526-6536.
10. Benatar T, Iacampo S, Tkalec L and Ratcliffe MJ. (1991). Eur. J. Immunol., 21, 2529-2536.
11. Benatar T, Tkalec L and Ratcliffe MJ. (1992). Proc. Natl. Acad. Sci. USA, 89, 7615-7619.
12. Beug H, Müller H, Grieser S, Doederlein G and Graf T. (1981). Virology, 115, 295-309.
13. Bhat GV and Temin HM. (1990). Oncogene, 5, 625-634.
14. Boehmelt G, Madruga J, Dörfler P, Briegel K, Schwarz H, Enrietto PJ and Zenke M. (1995). Cell, 80, 341-352.
15. Boehmelt G, Walker A, Kabrun N, Mellitzer G, Beug H, Zenke M and Enrietto PJ. (1992). EMBO J., 11, 4641-4652.
16. Bose Jr HR. (1992). Biochim. Biophys. Acta, 1114, 1-17.
17. Capobianco AJ and Gilmore TD. (1991). Oncogene, 6, 2203-2210.
18. Copobianco AJ and Gilmore TD. (1993). Virology, 193, 160-170.
19. Capobianco AJ, Chang D, Mosialos G and Gilmore TD. (1992). J. Virol., 66, 3758-3767.
20. Capobianco AJ, Simmons DL and Gilmore TD. (1990). Oncogene, 5, 257-265.
21. Carrasco D, Perez P, Lewin A and Bravo R. (1997). J. Exp. Med., 186, 279-288.
22. Carrasco D, Rizzo CA, Dorfman K and Bravo R. (1996). EMBO J., 15, 3640-3650.
23. Chang C-C, Zhang J, Lombardi L, Neri A and Dalla-Favera R. (1995). Mol. Cell. Biol., 15, 5180-5187.
24. Charman HP, Gilden RV and Oroszlan S. (1979). J. Virol., 26, 1221-1225.
25. Chen C, Agnès F and Gélinas C. (1999). Mol. Cell. Biol., 19, 307-316.
26. Chen E, Hrdlicková R, Nehyba J, Longo DL, Bose Jr HR and Li C-CH. (1998). J. Biol. Chem., 273, 35201-35207.
27. Chen F and Ghosh G. (1999). Oncogene, 18, 6845-6852.
28. Chen I and Temin HM. (1982). Cell, 31, 111-120.
29. Chen I, Mak T, O'Rear J and Temin HM. (1981). J. Virol., 40, 800-811.
30. Chen I, Wilhelmsen K and Temin HM. (1983). J. Virol., 45, 104-113.
31. Chen L, Lim MY, Bose Jr HR and Bishop JM. (1988). Proc. Natl. Acad. Sci. USA, 85, 549-553.
32. Davis N, Bargmann W, Lim M-Y and Bose Jr HR. (1990). J. Virol., 64, 584-591.
33. Davis N, Ghosh S, Simmons DL, Tempst P, Liou H-C, Baltimore D and Bose Jr HR. (1991). Science, 253, 1268-1271.
34. Diehl JA and Hannink M. (1993). J. Virol., 67, 7161-7167.
35. Diehl JA, McKinsey TA and Hannink M. (1993). Mol. Cell. Biol., 13, 1769-1778.
36. Enrietto PJ. (1990). Sem. Cancer Biol., 1, 399-405.
37. Epinat J-C, Kazandjian D, Harkness DD, Petros S, Dave J, White DW and Gilmore TD. (1999). Oncogene, in press.
38. Franklin RB, Kang C-Y, Min-min Wan K and Bose Jr HR. (1977). Virology, 83, 313-321.
39. Franklin RB, Maldonado RL and Bose Jr HR. (1974). Intervirology, 3, 342-352.
40. Fujii M, Minamino M, Nomura M, Miyamoto K-I, Tanaka J and Seiki M. (1996). Oncogene, 12, 2193-2202.
41. Fujii M, Minamino T, Nomura M, Miyamoto K, Tanaka J and Seiki M. (1997). Leukemia, 11, 402-404.
42. Fujita T, Nolan GP, Ghosh S and Baltimore D. (1992). Genes Dev., 6, 775-787.
43. Garry RF and Bose Jr HR. (1981). Virology, 113, 403-407.
44. Garson K and Kang C-Y. (1986). Biochem. Biophys. Res. Comm., 134, 716-722.
45. Garson K and Kang C-Y. (1990). Oncogene, 5, 1431-1434.
46. Garson K, Percival H and Kang C-Y. (1990). Virology, 177, 106-115.
47. Gélinas C and Temin HM. (1988). Oncogene, 3, 349-355.
48. Gilmore TD. (1991). Trends Genet., 7, 318-322.
49. Gilmore TD. (1992). Cancer Surv., 15, 69-87.
50. Gilmore TD and Temin HM. (1986). Cell, 44, 791-800.
51. Gilmore TD and Temin HM. (1988). J. Virol., 62, 703-714.
52. Gilmore TD, Koedood M, Piffat KA and White DW. (1996). Oncogene, 13, 1367-1378.
53. Gilmore TD, White DW, Sarkar S and Sif S. (1995). In: The DNA Provirus: Howard Temin's Scientific Legacy. Cooper GM, Greenberg Temin R and Sugden B (eds). ASM Press: Washington DC. pp. 109-128.
54. Grumont RH, Rourke IJ and Gerondakis S. (1999). Genes Dev., 13, 400-411.
55. Hannink M and Temin HM. (1989). Mol. Cell. Biol., 9, 4323-4336.
56. Hannink M and Temin HM. (1991). Crit. Rev. Oncogen., 2, 293-309.
57. Herzog NK and Bose Jr HR. (1986). Proc. Natl. Acad. Sci. USA, 83, 812-816.
58. Hodgson J and Enrietto PJ. (1995). J. Virol., 69, 1971-1979.
59. Hoelzer JD, Franklin RB and Bose Jr HR. (1979). Virology, 93, 20-30.
60. Hoezler JD, Lewis RB, Wasmuth CR and Bose Jr HR. (1980). Virology, 100, 462-474.
61. Hrdlicková R, Nehyba J and Bose Jr HR. (1995a). J. Virol., 69, 3369-3380.
62. Hrdlicková R, Nehyba J and Humphries EH. (1994a). J. Virol., 68, 308-319.
63. Hrdlicková R, Nehyba J and Humphries EH. (1994b). J. Virol., 68, 2371-2382.
64. Hrdlicková R, Nehyba J, Roy A, Humphries EH and Bose Jr HR. (1995b). J. Virol., 69, 403-413.
65. Hu SSF, Lai MMC, Wong TC, Cohen RS and Sevoian M. (1981). J. Virol., 37, 899-907.
66. Hunter E, Brown AS and Bennett JC. (1978). Proc. Natl. Acad. Sci. USA, 75, 2708-2712.
67. Inoue J-I, Kerr LD, Ransone LJ, Bengal E, Hunter T and Verma IM. (1991). Proc. Natl. Acad. Sci. USA, 88, 3715-3719.
68. Inuzuka M, Ishikawa H, Kumar S, Gélinas C and Ito Y. (1994). Oncogene, 9, 133-140.
69. Ishikawa H, Asano M, Kanda T, Gélinas C and Ito Y. (1993). Oncogene, 8, 2889-2896.
70. Kabrun N and Enrietto PJ. (1994). Sem. Cancer Biol., 5, 103-112.
71. Kabrun N, Bumstead N, Hayman MJ and Enrietto PJ. (1990). Mol. Cell. Biol., 10, 4788-4794.
72. Kabrun N, Hodgson JW, Doemer M, Mak G, Franza BR and Enrietto PJ. (1991). Proc. Natl. Acad. Sci. USA, 88, 1783-1787.
73. Kamens J and Brent R. (1991). New Biol., 3, 1005-1013.
74. Kamens J, Richardson P, Mosialos G, Brent R and Gilmore T. (1990). Mol. Cell. Biol., 10, 2840-2847.
75. Karin M. (1999). Oncogene, 18, 6867-6874.
76. Keller LH, Rufner R and Sevoian M. (1979). Infect. Immun., 25, 694-701.
77. Kieran M, Blank V, Logeat F, Vandekerckhove J, Lottspeich F, Le Bail O, Urban MB, Kourilsky P, Baeurele PA and Israël A. (1990). Cell, 62, 1007-1018.
78. Kochel T and Rice NR. (1992). Oncogene, 7, 567-572.
79. Kochel T, Mushinski JF and Rice NR. (1991). Oncogene, 6, 615-626.
80. Koedood Zhao M, Wang Y, Murphy K, Yi J, Beckerle MC and Gilmore TD. (1999). Gene Expression, in press.
81. Kralova J, Liss AS, Bargmann W and Bose Jr HR. (1998). Mol. Cell. Biol., 18, 2997-3009.
82. Kralova J, Schatzle JD, Bargmann W and Bose Jr HR. (1994). J. Virol., 68, 2073-2083.
83. Kumar S, Rabson AB and Gélinas C. (1992). Mol. Cell. Biol., 12, 3094-3106.
84. Larose RN and Sevoian M. (1965). Avian Dis., 9, 604-610.
85. Lee JW, Choi H-S, Gyuris J, Brent R and Moore DD. (1995). Mol. Endocrinol., 9, 243-254.
86. Lee R-M, Gillet G, Burnside J, Thomas SJ and Neiman P. (1999). Genes Dev., 13, 718-728.
87. Lewis R, McClure J, Rup B, Niesel DW, Garry RF, Hoelzer JD, Nazerian K and Bose Jr HR. (1981). Cell, 25, 421-431.
88. Lim M-Y, David N, Zhang J and Bose Jr HR. (1990). Virology, 175, 149-160.
89. Maldonado RL and Bose Jr HR. (1971). J. Virol., 8, 813-815.
90. Marmor MD, Benatar T and Ratcliffe MJ. (1993). J. Exp. Med., 177, 647-656.
91. McDonnell PC, Kumar S, Rabson AB and Gélinas C. (1992). Oncogene, 7, 163-170.
92. Miller CK and Temin HM. (1986). J. Virol., 58, 75-80.
93. Miller CK, Embretson JE and Temin HM. (1988). J. Virol., 62, 1219-1226.
94. Moore BE and Bose Jr HR. (1988a). Mutation Res., 195; 79-90.
95. Moore BE and Bose Jr HR. (1988b). Virology, 162, 377-387.
96. Morrison LE, Boehmelt G and Enrietto PJ. (1992). Oncogene, 7, 1137-1147.
97. Morrison LE, Boehmelt G, Beug H and Enrietto P. (1991). Oncogene, 6, 1657-1666.
98. Morrison LE, Kabrun N, Mudri S, Hayman MJ and Enrietto PJ. (1989). Oncogene, 4, 677-683.
99. Mosialos G. (1993). PhD Thesis, Boston University.
100. Mosialos G and Gilmore TD. (1993). Oncogene, 8, 721-730.
101. Mosialos G, Hamer P, Capobianco AJ, Laursen RA and Gilmore TD. (1991). Mol. Cell. Biol., 11, 5867-5877.
102. Mussman HC and Twiehaus MJ. (1971). Avian Dis., 15, 483-502.
103. Neyyba J, Hrdlicková R and Bose Jr HR. (1997). Oncogene, 14, 2881-2897.
104. Nehyba J, Hrdlicková R and Humphries EH. (1994). J. Virol., 68, 2039-2050.
105. Neiman PE, Thomas SJ and Loring G. (1991). Proc. Natl. Acad. Sci. USA, 88, 5857-5861.
106. Noori-Daloii MR, Swift RA, Rung H-J, Crittenden LB and Witter RL. (1981). Nature, 294, 574-576.
107. Nuñez G, Benedict MA, Hu Y and Inohara N. (1998). Oncogene, 17, 3237-3245.
108. Olson LD. (1967). Am. J. Veterinary Res., 28, 1501-1507.
109. Pahl HL. (1999). Oncogene, 18, 6853-6866.
110. Peterson DA and Levine AS. (1971). Avian Dis., 15, 336-347.
111. Petrenko O, Ischenko I and Enrietto PJ. (1995). Gene, 160, 305-306.
112. Pentrenko O, Ischenko I and Enrietto PJ. (1997). Oncogene, 15, 1671-1680.
113. Purchase HG and Witter RJ. (1975). In: Current Topics in Microbiology and Immunology, Vogt PK (ed.) Springer-Verlag: New York, USA. pp. 103-124.
114. Purchase HG, Ludford C, Nazerian K and Cox HW. (1973). J. Natl. Cancer Inst., 51, 489-497.
115. Rayet B and Gélinas C. (1999). Oncogene, 18, 6938-6958.
116. Rice NR and Gilden RV. (1988). In: The Oncogene Handbook. Reddy EP, Skalka AM and Curran T (eds). Elsevier Science Publishers: Amsterdam, Holland, pp. 495-512.
117. Rice NR, Copeland TD, Simek S, Oroszlan S and Gilden RV. (1986). Virology, 149, 217-229.
118. Rice NR, Hiebsch RR, Gonda MA, Bose Jr HR and Gilden RV. (1982). J. Virol., 42, 237-252.
119. Richardson PM and Gilmore T. (1991). J. Virol., 65, 3122-3130.
120. Robinson FR and Twiehaus MJ. (1974), Avian Dis., 18, 278-288.
121. Romero P and Humphries EH. (1995). J. Virol., 69, 301-307.
122. Rottjakob EM, Sachdev S, Leanna CA, McKinsey TA and Hannink M. (1996). J. Virol., 70, 3176-3188.
123. Rup BJ, Spence JL, Hoelzer JD, Lewis RB, Carpenter CR, Rubin AS and Bose Jr HR. (1979). J. Immunol., 123, 1362-1370.
124. Sachdev S and Hannink M. (1998). Mol. Cell. Biol., 18, 5445-5456.
125. Sachdev S, Diehl JA, McKinsey TA, Hans A and Hannink M. (1997). Oncogene, 14, 2585-2594.
126. Sarkar S and Gimore TD. (1993). Oncogene, 8, 2245-2252.
127. Sasaki T and Koyama H. (1989). Avian Pathol., 18, 307-319.
128. Schat KA, Pratt WD, Morgan R, Weinstock D and Calnek BW. (1992). Avian Dis., 36, 432-439.
129. Schatzle JD, Kralova J and Bose Jr HR. (1995). J. Virol., 69, 5383-5390.
130. Schwartz RC and Witte ON. (1988). Virology, 165, 182-192.
131. Sevoian M, Larose RN and Chamberlain DM. (1964). Avian Dis., 8, 336-347.
132. Shibuya T, Chen I, Mowstan A and Mak T. (1982). Cancer Res., 42, 2722-2728.
133. Sif S, Capobianco AJ and Gilmore TD. (1993). Oncogene, 8, 2501-2509.
134. Sif S and Gilmore TD. (1993). J. Virol., 67, 7612-7617.
135. Sif S and Gilmore TD. (1994). J. Virol., 68, 7131-7138.
136. Simek S and Rice NR. (1988a). J. Virol., 62, 4730-4736.
137. Simek S and Rice NR. (1988b). Oncogene Res., 2, 103-119.
138. Simek SL, Stephens RM and Rice NR. (1986). J. Virol., 59, 120-126.
139. Smardova J, Walker A, Morrison LE, Kabrun N and Enrietto P. (1995). Oncogene, 10, 2017-2026.
140. Stephens RM, Rice NR, Hiebsch RR, Bose Jr HR and Gilden RV. (1983). Proc. Natl. Acad. Sci. USA, 80, 6229-6233.
141. Storms RW and Bose Jr HR. (1992). Virology, 188, 765-777.
142. Swift RA, Shaller E, Witter RL and Kung H-J. (1985). J. Virol., 54, 869-872.
143. Sylla BS and Temin HM. (1986). Mol. Cell. Biol., 6, 4709-4716.
144. Taylor HW and Olson LD. (1971). Avian Dis., 15, 629-637.
145. Taylor HW and Olson LD. (1972). Avian Dis., 16, 330-335.
146. Taylor HW and Olson LD. (1973a). Avian Dis., 17, 782-794.
147. Taylor HW and Olson LD. (1973b). Avian Dis., 17, 794-802.
148. Temin HM. (1990). In: The Cellular and Molecular Biology of Human Carcinogenesis. Academic Pres, Inc: New York, NY. pp. 175-187.
149. Theilen GH, Zeigel and Twiehaus MJ. (1996). J. Natl. Cancer Inst., 37, 731-743.
150. Tung HY, Bargmann WJ and Bose Jr HR. (1988a). Biochem. Biophys. Res. Comm., 152, 441-448.
151. Tung HYL, Bargmann WJ, Lim MY and Bose Jr HR. (1988b). Proc. Natl. Acad. Sci. USA, 88, 2479-2483.
152. Walker AK and Enrietto PJ. (1996). Oncogene, 12, 2515-2525.
153. Walker WH, Stein B, Ganchi PA, Hoffman JA, Kaufmann PA, Ballard DW, Hannink M and Greene WC. (1992). J. Virol., 66, 5018-5029.
154. Walro D, Herzog NK, Zhang J, Lim M and Bose Jr HR. (1987). Virology, 160, 433-444.
155. White DW and Gilmore TD. (1993). J. Virol., 67, 6876-6881.
156. White DW and Gilmore TD. (1996). Oncogene, 13, 891-899.
157. White DW, Pitoc GA and Gilmore TD. (1996). Mol. Cell. Biol., 16, 1169-1178.
158. White DW, Roy A and Gilmore TD. (1995). Oncogene, 10, 857-868.
159. Wilhelmsen K and Temin HM. (1984). J. Virol., 49, 521-529.
160. Wilhelmsen KC, Eggleton K and Temin HM. (1984). J. Virol., 52, 172-182.
161. Witter RL and Crittenden LB. (1979). Intl. J. Cancer, 23, 673-678.
162. Witter RL, Lee LF, Bacon LD and Smith EJ. (1979). Infect. Immun., 26, 90-98.
163. Witter RL, Smith EJ and Crittenden LB. (1981). Avian Dis., 25, 374-394.
164. Wong TC and Lai MMC. (1981). Virology, 111, 289-293.
165. Xu X, Prorock C, Ishikawa H, Maldonado E, Ito Y and Gélinas C. (1993). Mol. Cell. Biol., 13, 6733-6741.
166. Xu X, and Gélinas C. (1995). Virology, 207, 362-368.
167. Xu X, and Gélinas C. (1997). Oncogene, 14, 1521-1530.
168. You M, Ku P-T, Hrdlicková R and Bose Jr HR. (1997). Mol. Cell. Biol., 17, 7328-7341.
169. Zhang G and Humphries EH. (1996). Oncogene, 12, 1153-1157.
170. Zhang G, Slaughter C and Humphries EH. (1995). Mol. Cell. Biol., 15, 1806-1816.
171. Zhang J, Bargmann W and Bose Jr HR. (1989). Mol. Cell. Biol., 9, 4970-4976.
172. Zhang J, Olson W, Ewert D, Bargmann W and Bose Jr HR. (1991). Virology, 183, 457-466.
173. Zong W-X, Bash J and Gélinas C. (1998). Cell Death Differ., 5, 963-972.
174. Zong W-X, Edelstein LC, Chen C, Bash J and Gélinas C. (1999). Genes Dev., 13, 382-387.
175. Zong W-X, Farrell M, Bash J and Gélinas C, (1997). Oncogene, 15, 971-980.
176. Zurovec M, Petrenko O, Roll R and Enrietto PJ. (1998). Oncogene, 16, 3133-3142.